Literature DB >> 18508320

Impact of genetic variation on perioperative bleeding.

Jochen D Muehlschlegel1, Simon C Body.   

Abstract

Variation in bleeding in the perioperative period is a complex and multifactorial event associated with immediate and delayed consequences for the patient and health care resources. Little is known about the complex genetic influences on perioperative bleeding. With the discovery of multiple variations in the human genome and ever-growing databases of well-phenotyped surgical patients, better identification of patients at risk of bleeding is becoming a reality. In this review, polymorphisms in the platelet receptor genes, plasminogen activator inhibitor, and angiotensin genes among others will be discussed. We will explore the nature, effects, and implications of the genetics that influence perioperative bleeding above and beyond surgical bleeding, particularly in cardiac surgery. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508320      PMCID: PMC5266599          DOI: 10.1002/ajh.21205

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  81 in total

1.  Transfusion in coronary artery bypass grafting is associated with reduced long-term survival.

Authors:  Colleen Gorman Koch; Liang Li; Andra I Duncan; Tomislav Mihaljevic; Floyd D Loop; Norman J Starr; Eugene H Blackstone
Journal:  Ann Thorac Surg       Date:  2006-05       Impact factor: 4.330

2.  Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study.

Authors:  John F Carlquist; Benjamin D Horne; Joseph B Muhlestein; Donald L Lappé; Bryant M Whiting; Matthew J Kolek; Jessica L Clarke; Brent C James; Jeffrey L Anderson
Journal:  J Thromb Thrombolysis       Date:  2006-12       Impact factor: 2.300

3.  The relationship between ABO blood group and the risk of bleeding during vitamin K antagonist treatment.

Authors:  A A Garcia; J F van der Heijden; J C M Meijers; F R Rosendaal; P H Reitsma
Journal:  J Thromb Haemost       Date:  2006-06       Impact factor: 5.824

4.  Anti-thrombotic action of clopidogrel and P1(A1/A2) polymorphism of beta3 integrin in patients with coronary artery disease not being treated with aspirin.

Authors:  Jerzy Dropinski; Jacek Musial; Bogdan Jakiela; Wojciech Wegrzyn; Marek Sanak; Andrew Szczeklik
Journal:  Thromb Haemost       Date:  2005-12       Impact factor: 5.249

5.  Deletion polymorphism in the angiotensin-converting enzyme gene as a thrombophilic risk factor after hip arthroplasty.

Authors:  C S Philipp; A Dilley; P Saidi; B Evatt; H Austin; J Zawadsky; D Harwood; D Ellingsen; E Barnhart; D J Phillips; W C Hooper
Journal:  Thromb Haemost       Date:  1998-12       Impact factor: 5.249

Review 6.  Future directions in utilization review: the role of transfusion algorithms.

Authors:  L T Goodnough; G J Despotis
Journal:  Transfus Sci       Date:  1998-03

7.  Deficiency of plasma plasminogen activator inhibitor 1 results in hyperfibrinolytic bleeding.

Authors:  M H Lee; E Vosburgh; K Anderson; J McDonagh
Journal:  Blood       Date:  1993-05-01       Impact factor: 22.113

Review 8.  Pharmacogenomics of platelet responsiveness to aspirin.

Authors:  Nauder Faraday; Diane M Becker; Lewis C Becker
Journal:  Pharmacogenomics       Date:  2007-10       Impact factor: 2.533

9.  Myocardial infarction in patients aged less than 40 years. Frequency of BclI polymorphism in the fibrinogen beta-chain gene and plasma fibrinogen.

Authors:  Krzysztof Lewandowski; Piotr Kwaśnikowski; Waldemar Elikowski; Krystyna Zawilska
Journal:  Kardiol Pol       Date:  2003-09       Impact factor: 3.108

10.  Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and coagulation factor VII Arg353-->Gln polymorphism in Korean patients with coronary artery disease.

Authors:  J Song; Y M Yoon; H J Jung; S H Hong; H Park; J Q Kim
Journal:  J Korean Med Sci       Date:  2000-04       Impact factor: 2.153

View more
  3 in total

1.  Polymorphism in the protease-activated receptor-4 gene region associates with platelet activation and perioperative myocardial injury.

Authors:  Jochen D Muehlschlegel; Tjörvi E Perry; Kuang-Yu Liu; Amanda A Fox; Shane A Smith; Peter Lichtner; Charles D Collard; Stanton K Shernan; John H Hartwig; Simon C Body; Karin M Hoffmeister
Journal:  Am J Hematol       Date:  2012-01-07       Impact factor: 10.047

2.  Molecular classification of blood and bleeding disorder genes.

Authors:  Batoul Baz; Mohamed Abouelhoda; Dorota Monies; Tarek Owaidah; Majed Dasouki; Nada Al Tassan
Journal:  NPJ Genom Med       Date:  2021-07-16       Impact factor: 8.617

3.  Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report.

Authors:  Francesco Rodeghiero; Ingrid Pabinger; Margaret Ragni; Rezan Abdul-Kadir; Erik Berntorp; Victor Blanchette; Imre Bodó; Alessandro Casini; Paolo Gresele; Riitta Lassila; Frank Leebeek; David Lillicrap; Diego Mezzano; Patrizia Noris; Alok Srivastava; Alberto Tosetto; Jerzy Windyga; Barbara Zieger; Mike Makris; Nigel Key
Journal:  Hemasphere       Date:  2019-09-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.